Join our live webinar on post-ASCO and ESMO-GI on Thursday, 9 July 2026 19:00 - 20:30 CET
*Timely summary and practical implications discussed by international experts in digestive oncology*
https://t.co/KUXyl8UuS7
registration https://t.co/eRfV5stIXp
Reducing digestive cancer mortality starts even before treatment – with stronger prevention and screening. Hear from Thomas Seufferlein from @ESDO_tweets on the key actions needed to move digestive cancer prevention forward 👉 https://t.co/Lly9gtvT0o
It is our great pleasure to invite you to the 10th ESDO Masterclass in Nantes, France, on 19 & 20 June 2026
The programme will focus on the most recent advances in Digestive Oncology and on novel approaches in treatments
free registration https://t.co/SAE9a1fpsX
ESDO webinar *New data on GI Cancer at ASCO-GI 2026* Thursday, 29 January 18:00-19:30
Join this live webinar with leading European experts, translating ASCO-GI 2026 data into practical treatment algorithms for clinical decision-making https://t.co/Y8y8h1iqwD
What are the criteria for organ preservation in Colorectal Cancer care? In our latest podcast, Dr. Randrian discusses different approaches with expert @AndreaCercek from @MSKCancerCenter
🎧 Listen here → https://t.co/61XNkqhgYE
You missed the webinar *New data on GI cancer at ESMO 2025: integration in treatment algorithms* ? #esmo2025#esmo25
the recording is online https://t.co/khKNffQhMo
1st ESDO Live Webinar: 6 Nov 2025 / 20:00 - 21:30
New data on GI cancer at ESMO 2025: integration in treatment algorithms #ESMO2025#ESMO25
Gain first-hand insights and engage with thought leaders in the field. REGISTRATION https://t.co/S3zvhnIZrP
Turning ambitious ideas 💡 into reality with @ArchibugiLivia@my_ueg and @EurPancClub !!!
🟢 The quality indicators in pancreas cancer project is now up and running.. to elevate the level of care in Europe and beyond!
Thank you to all the amazing experts for participating! 🚀
listen to the NEW ESDO PODCAST! Dr. Violaine RANDRIAN, gastroenterologist at CHU Poitiers, France discusses the characteristics and management of Appendix Cancer with Dr. Michael Foote, GI oncologist at MSKCC, New York, USA https://t.co/W5rgKPuUxW
Today is a good day! Our new paper on a Belgian cohort of 283 high grade neuroendocrine neoplasms receives @OncoThor's stamp of approval. More on NET G3 vs NEC, functional imaging,... through https://t.co/skdjIsfRQ8 @enetwerkbe@WLybaert
🟢🟢Delight to launch with @ArchibugiLivia the new @my_ueg project on “Quality indicators in pancreatic ductal adenocarcinoma”
From Vienna 🇦🇹 we demand better care for our patients !!!